​Prof. Dr. Abdullah Owaidi Al-Abbadi, Director of the Stem Cell Therapy Center, received Dr. David Collingridge, Visiting Professor of Global Oncology at the College of Cancer and Pharmaceutical Sciences in Kingzhou, Editor-in-Chief of The Lancet Oncology and Publishing Director of The Lancet's specialized journals.

 Prof. Al-Abadi gave the visiting guest an explanation about the center, its inception and medical mission, and discussed the possibility of cooperation, and the guest toured the center and praised the center's achievements and good reputation in the field of autologous and non-autologous human cells and modifying them for various therapeutic purposes.